Translating the editor: using genome editing tools to develop therapeutics

Associate Faculty Member and F1000 Specialist Jeffrey Hannah recently attended the New York Academy of Sciences meeting on Harnessing the potential of genome editing for drug discovery: translational frontiers of in vitro and in vivo applications. Here, he tells us about the rapidly expanding uses of the technology and what he learnt in the session. Continue reading →
Source: Naturally Selected - Category: Biomedical Science Authors: Tags: F1000 Specialists Faculty Members Genomics & Genetics Guest post Source Type: blogs